Atlas Trials

A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED)

Clinical trial NCT07418034 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07418034
Sponsor
University of Maryland, Baltimore
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Head and Neck CancerHead and Neck Squamous Cell CancerHead and Neck Squamous Cell CarcinomaOropharyngeal CarcinomaOropharyngeal Squamous Cell Carcinoma (OPSCC)Oropharyngeal Human Papillomavirus-Positive Squamous Cell CarcinomaOropharyngeal Squamous Cell CarcinomaOropharyngeal Squamous Cell Carcinoma (SCC)Oropharyngeal Squamous Cell Carcinoma (OPSCCA)Oropharyngeal CancerOropharyngeal Squamous Cell CancerHPV Positive Oropharyngeal Squamous Cell Carcinoma
Start date
2026-09-01
Primary completion
2031-05-01
Enrollment
132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.